Array
(
[id] => 11243584
[patent_doc_number] => 09469615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 13/996361
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49873
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996361
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996361 | Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators | Dec 18, 2011 | Issued |
Array
(
[id] => 10162478
[patent_doc_number] => 09193695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-24
[patent_title] => '1, 2, 4-triazolone derivative and use thereof as an antagonist on the arginine-vasopressin 1B receptor'
[patent_app_type] => utility
[patent_app_number] => 13/824174
[patent_app_country] => US
[patent_app_date] => 2011-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40944
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13824174
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/824174 | 1, 2, 4-triazolone derivative and use thereof as an antagonist on the arginine-vasopressin 1B receptor | Sep 29, 2011 | Issued |
Array
(
[id] => 9081969
[patent_doc_number] => 20130267499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 13/809581
[patent_app_country] => US
[patent_app_date] => 2011-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31337
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809581
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/809581 | Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors | Jul 10, 2011 | Issued |
Array
(
[id] => 8587146
[patent_doc_number] => 20130005966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'PROCESS FOR THE PREPARATION OF IMIDAZO[2,1-B][1,3]BENZOTHIAZOLE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/508020
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 41818
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508020
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508020 | Process for the preparation of imidazo[2,1-B][1,3]benzothiazole derivatives | Nov 3, 2010 | Issued |